Mid Staffs and mortality dataBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f638 (Published 30 January 2013) Cite this as: BMJ 2013;346:f638
- Fiona Godlee, editor, BMJ
Stafford Hospital in England’s West Midlands was just one of many medium sized hospitals treating a wide range of medical and surgical conditions within the NHS. But then, in 2007, the health analytics company Dr Foster reported higher than expected death rates among its patients. Few could have predicted the long and murky chain of events that would follow, culminating in a public inquiry chaired by Robert Francis (see our timeline at http://tw.gs/YxS0gV). The inquiry’s findings will be published next week.
This has been a bitter episode in the NHS’s history which, like the Bristol heart surgery scandal in 1998, is likely to echo down the years. Evidence given to the inquiry over the past 18 months speaks of problems well before 2007, including target driven managers, poor standards of nursing care and cleanliness, a culture of bullying and intimidation, serious complaints from patients and relatives being ignored, and doctors continuing to refer and treat patients rather than speaking out. Patients and their relatives will be right to feel betrayed.
But what of that first public signal suggesting that something was wrong? Is the hospital standardised mortality rate (HSMR) a reliable indicator of poor standards of care? The methodology has its critics, chief among them Richard Lilford and colleagues at Birmingham University. And it was these critics to whom the beleaguered Mid Staffs strategic health authority turned for an opinion on the trust’s unflattering mortality data. The resulting report, highly critical of the HSMR’s ability to reflect differences in quality of care, was published in the BMJ (2009;338:b780). At the authors’ request, it was published on the same day as a Healthcare Commission report into Mid Staffs. Was the BMJ used as part of a concerted effort to discredit the HSMR?
We asked Nigel Hawkes to investigate. After talking to all parties he finds no clear evidence to support this claim, nor the claim that Mid Staffs orchestrated efforts to manipulate mortality data (doi:10.1136/bmj.f562). What he does find is a “tangled tale” of coding changes and false reassurances, which almost certainly delayed the necessary action to tackle what we now know were fatal failures of care.
As Hawkes reports, the NHS is now using a new version of the HSMR: summary hospital level mortality indicators (SHMIs), and five English hospitals have just been named as having higher rates than expected (BMJ 2013;346:f554). But we are being urged not to see these as a definitive judgment but more as an early warning.
What does all this mean for future attempts to track the quality of hospital care? While acknowledging concerns about existing methods, Harlan Krumholz and colleagues seem optimistic (doi:10.1136/bmj.f620). The science of healthcare measurement is advancing rapidly, they say, as is the availability of higher quality data. Both promise a more accurate picture of how our systems of care are performing. But on their own they won’t be enough. Scrutiny, scepticism, listening, and courage are needed if we are to promote effective clinical strategies, give patients the information they need, and reward excellence, not just reputation. The Bristol scandal woke us up to the need to share data on clinical outcomes and to speak out when we witness poor quality or unsafe care. But that was 15 years ago. How much has really changed?
Cite this as: BMJ 2013;346:f638